Atovaquone and proguanil hydrochloride
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Kiran Singh, M.D. [2]
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Overview
Atovaquone and proguanil hydrochloride is {{{aOrAn}}} {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. Common adverse reactions include {{{adverseReactions}}}.
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
There is limited information regarding Atovaquone and proguanil hydrochloride FDA-Labeled Indications and Dosage (Adult) in the drug label.
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Atovaquone and proguanil hydrochloride in adult patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Atovaquone and proguanil hydrochloride in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
There is limited information regarding Atovaquone and proguanil hydrochloride FDA-Labeled Indications and Dosage (Pediatric) in the drug label.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
There is limited information regarding Off-Label Guideline-Supported Use of Atovaquone and proguanil hydrochloride in pediatric patients.
Non–Guideline-Supported Use
There is limited information regarding Off-Label Non–Guideline-Supported Use of Atovaquone and proguanil hydrochloride in pediatric patients.
Contraindications
There is limited information regarding Atovaquone and proguanil hydrochloride Contraindications in the drug label.
Warnings
There is limited information regarding Atovaquone and proguanil hydrochloride Warnings' in the drug label.
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Atovaquone and proguanil hydrochloride Clinical Trials Experience in the drug label.
Postmarketing Experience
There is limited information regarding Atovaquone and proguanil hydrochloride Postmarketing Experience in the drug label.
Drug Interactions
There is limited information regarding Atovaquone and proguanil hydrochloride Drug Interactions in the drug label.
Use in Specific Populations
Pregnancy
Pregnancy Category (FDA):
There is no FDA guidance on usage of Atovaquone and proguanil hydrochloride in women who are pregnant.
Pregnancy Category (AUS):
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Atovaquone and proguanil hydrochloride in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Atovaquone and proguanil hydrochloride during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride in women who are nursing.
Pediatric Use
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride in pediatric settings.
Geriatic Use
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride in geriatric settings.
Gender
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride with respect to specific gender populations.
Race
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Atovaquone and proguanil hydrochloride in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Atovaquone and proguanil hydrochloride in patients who are immunocompromised.
Administration and Monitoring
Administration
There is limited information regarding Atovaquone and proguanil hydrochloride Administration in the drug label.
Monitoring
There is limited information regarding Atovaquone and proguanil hydrochloride Monitoring in the drug label.
IV Compatibility
There is limited information regarding the compatibility of Atovaquone and proguanil hydrochloride and IV administrations.
Overdosage
There is limited information regarding Atovaquone and proguanil hydrochloride overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.
Pharmacology
There is limited information regarding Atovaquone and proguanil hydrochloride Pharmacology in the drug label.
Mechanism of Action
There is limited information regarding Atovaquone and proguanil hydrochloride Mechanism of Action in the drug label.
Structure
There is limited information regarding Atovaquone and proguanil hydrochloride Structure in the drug label.
Pharmacodynamics
There is limited information regarding Atovaquone and proguanil hydrochloride Pharmacodynamics in the drug label.
Pharmacokinetics
There is limited information regarding Atovaquone and proguanil hydrochloride Pharmacokinetics in the drug label.
Nonclinical Toxicology
There is limited information regarding Atovaquone and proguanil hydrochloride Nonclinical Toxicology in the drug label.
Clinical Studies
There is limited information regarding Atovaquone and proguanil hydrochloride Clinical Studies in the drug label.
How Supplied
There is limited information regarding Atovaquone and proguanil hydrochloride How Supplied in the drug label.
Storage
There is limited information regarding Atovaquone and proguanil hydrochloride Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Atovaquone and proguanil hydrochloride |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Atovaquone and proguanil hydrochloride |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Atovaquone and proguanil hydrochloride Patient Counseling Information in the drug label.
Precautions with Alcohol
Alcohol-Atovaquone and proguanil hydrochloride interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
There is limited information regarding Atovaquone and proguanil hydrochloride Brand Names in the drug label.
Look-Alike Drug Names
There is limited information regarding Atovaquone and proguanil hydrochloride Look-Alike Drug Names in the drug label.
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.